Limontar® (Tablets) Instructions for Use
Marketing Authorization Holder
Biotiki MNPK, LLC (Russia)
ATC Code
A13A (General tonic preparations)
Active Substances
Succinic acid (BHP British Herbal Pharmacopoeia)
Citric acid (Ph.Eur. European Pharmacopoeia)
Dosage Form
| Limontar® | Soluble tablets 50 mg+200 mg: 30 pcs. |
Dosage Form, Packaging, and Composition
Soluble tablets white tablets with marbling elements, biconvex in shape.
| 1 tab. | |
| Citric acid monohydrate | 50 mg |
| Succinic acid | 200 mg |
Excipients: magnesium stearate – 3 mg.
30 pcs. – blister packs (1) – cardboard packs.
Clinical-Pharmacological Group
A drug that improves tissue metabolism and energy supply, reducing tissue hypoxia
Pharmacotherapeutic Group
Metabolic agent
Pharmacological Action
A combined medicinal product, a regulator of tissue metabolism, possesses antihypoxic and antioxidant properties, increases appetite, and reduces the toxic effect of ethanol.
By stimulating redox reactions, respiration processes, and ATP synthesis, it activates the physiological functions of organs and tissues (stimulates the body’s adaptive and compensatory-protective capabilities); increases mental and physical performance; improves the course of pregnancy, fetal growth and development; increases the secretion of gastric juice, the formation of hydrochloric acid and appetite; reduces the toxic effect of alcohol.
The effect appears 10-20 minutes after oral administration.
Pharmacokinetics
Succinic and citric acids are completely metabolized to water and carbon dioxide and do not accumulate.
Indications
Increasing the nonspecific reactivity of the body during pregnancy; prevention of complications in fetal hypoxia and hypotrophy, miscarriage; alcohol intoxication (mild and moderate severity); treatment of binge states in patients with chronic alcoholism (as part of complex therapy); alcohol withdrawal syndrome; asthenovegetative syndrome (asthenia, decreased performance, decreased appetite); as a “test breakfast” for the study of the secretory and acid-forming function of the stomach.
ICD codes
| ICD-10 code | Indication |
| F10.2 | Chronic alcoholism |
| F10.3 | Withdrawal state |
| F48.0 | Neurasthenia |
| O26.2 | Medical care for women with recurrent pregnancy loss |
| P05 | Slow fetal growth and fetal malnutrition |
| P20 | Intrauterine hypoxia |
| R63.0 | Anorexia |
| T51 | Toxic effect of alcohol |
| Z51.4 | Preparatory procedures for subsequent treatment or examination, not elsewhere classified |
| Z73.0 | Burn-out |
| ICD-11 code | Indication |
| 6A8Z | Affective disorders, unspecified |
| 6C40.2Z | Alcohol dependence, unspecified |
| 6C40.4Z | Alcohol withdrawal syndrome, unspecified |
| 6C40.Z | Disorders due to alcohol use, unspecified |
| 8D44.Y | Other specified alcohol-related neurological disorders |
| JA65.4 | Medical care for pregnant woman with history of habitual abortion |
| KA20.Z | Disorders of newborn related to slow fetal growth or fetal malnutrition, unspecified |
| KB20.Z | Intrauterine hypoxia, unspecified |
| MG43.7 | Anorexia |
| NE61 | Toxic effect of poisonous substances, chiefly nonmedicinal, not elsewhere classified |
| QB9A | Preparatory procedures for subsequent treatment |
| QD85 | Burn-out |
Dosage Regimen
| The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen. |
The drug is taken orally, before meals. Before administration, the tablet is crushed and dissolved in water with baking soda or mineral water.
For pregnant women, 1 tab./day is prescribed for 10 days in the first trimester (at 12-14 weeks of pregnancy) and in the second trimester (24-26 weeks of pregnancy). In the third trimester, it is prescribed 10-25 days before delivery. The total dose of the drug during pregnancy is 5-7.5 g.
For the prevention of alcohol intoxication – 1 tab. of the drug 20-60 minutes before alcohol consumption. For acute alcohol intoxication, the drug is prescribed 1 tab. 2-4 times/day at intervals of 1-2.5 hours. For relieving binge states in chronic alcoholism, 1 tab. is prescribed 3-4 times/day for 4-10 days, either independently or in combination with traditional medications.
As a means for a “test breakfast”, take orally, on an empty stomach, 1 tab. previously dissolved in 10-15 ml of water.
Adverse Reactions
Possible gastralgia, hypersecretion of gastric juice (usually these phenomena resolve on their own within 3-5 minutes).
In persons prone to arterial hypertension, with systematic use – increased blood pressure.
Contraindications
Arterial hypertension; ischemic heart disease; angina pectoris; gastric and duodenal ulcer (in the acute phase); glaucoma; late gestosis (severe form); hypersensitivity to the components of the drug.
Use in Pregnancy and Lactation
The drug is prescribed to pregnant women according to indications.
Special Precautions
If a feeling of heaviness in the epigastric region appears, it is prescribed after meals.
Drug Interactions
Weakens the effect of hypnotic drugs and tranquilizers.
Storage Conditions
Store at 2°C (36°F) to 25°C (77°F). Keep in original packaging, protected from light. Keep out of reach of children.
Dispensing Status
Over-the-Counter
Important Safety Information
This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.
Medical Disclaimer